chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Above vaccine received on Oct 27, 2022. On Nov 02, 2022 woke up with chest congestion/dry cough. Took home Covid-19 test = Negative. Went to local urgent care clinic, diagnosed withupper respratory illness. PCR Covid test = Positive. Sent home with 5 day Plaxovid regimen with instructions to self isolate/wear mask for 5 days. After completing 5 days Plaxovid regimen/isolation period on Nov 09, 2022 experienced "Plaxovid rebound", dry coughing, sneezing, runny nose, low grade temp of 99.8 degs. As of this date (Nov 16, 2022) self treatment has been self isolation, Day/Nyquil, temp = 98.4, slight lung congestion, dry cough.  NOTE: Had annual 65+ flu vaccination administered on Oct 21, 2022 prior to C-19 vaccination.
Covid moderna vaccine from vial that was expired by a couple of hours (vial was refrigerated the whole time). No adverse effect reported.
Severe flare of plaque psorisis on over 70 % of body starting right after second Pfizer COVID 19 vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 74 year old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), administered in arm right, administration date 20Mar2021 11:00 at the age of 73 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Plaque psoriasis (mild)" (unspecified if ongoing), notes: Plaque psoriasis (mild), Had mild psorisis for 40 years prior to COVID vaccine, Skin had been relatively clear of plaque psoriasis for the 5 months prior to the second COVID vaccine.Known allergies: No; "Coronary stent" (unspecified if ongoing), notes: Coronary stent. Concomitant medication(s) included, notes: other medications the patient received within 2 weeks of vaccination: LIPITOR statin 40mg; ASPIRIN [ACETYLSALICYLIC ACID87 mg]; vitimin D 1000. Vaccination history included: BNT162B2 (Dose Number: 1, Batch/Lot No: EH6201, Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM), administration date: 27Feb2021, when the patient was 73 years old, for COVID-19 Immunization. The following information was reported: PSORIASIS (medically significant) with onset Mar2021, outcome "recovering", described as "Severe flare of plaque psorisis on over 70 % of body starting right after second Pfizer COVID 19 vaccine". The event "severe flare of plaque psorisis on over 70 % of body starting right after second pfizer covid 19 vaccine" was evaluated at the physician office visit. Never a severe flare like this on all parts of patient's body. Have been put on a psoriasis biologic (Tremfya) in attempt to clear skin. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination nor tested for COVID-19 since the vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had migraine level headaches on 06/29/18.  By 6:00 PM both headaches and body aches were gone. Arm was no longer sore. Then on 6/30/2019 his arm swelled at the point of injection, it is hot, has approximately a 4 inch diameter hard swelling around the point of injection. He also has another swollen patch above the area of swelling toward his neck. The arm hurts again at the point of injection.
At 5 pm Friday 9/17 after getting vaccine I started to have sensitive skin, fatigue,  chills. the next morning , Saturday 9/18 i was still very fatigued and had a headache and dizziness along with the symptoms I previously mentioned. MY arm at the injection site was hot to the touch, red and swollen.  I slept most of the day and next day 9/19. On 9/20 most symptoms went away but i still was feeling fatigued and had a headache, I was mostly concerned about my arm as the swelling continued at the injection site. I made a virtual appt with a doctor at my clinic. She was not concerned.  I spoke with my work on 9/21 about my symptoms and they made me get covid tested, it was a negative test on 9/20. the fatigue and head ach didn't go away til 9/25. the swelling in my arm continued to get worse til it was the size of a baseball, it still felt hot. the swelling in the arm didn't go down until 9/28. at that point my skin became very itchy
Patient felt lightheaded, cold post vaccine. Patient moved to open area. Refusal signed.
Was administered a dose of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number K3YC7, expiry date 07-NOV-2022) for prophylaxis.   On 17-FEB-2023, the patient received Shingrix. On 17-FEB-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Was administered a dose of Shingrix). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 07-JUN-2023 At the time of reporting, the dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter did consent to follow up. The patient received the expired Shingrix vaccine, which led to expired vaccine used. This case was one of 3 cases, reported by same reporter.; Sender's Comments:  US-GSK-US2023080474:Same reporter US-GSK-US2023080477:Same reporter
Patient reported neck and arm pain for 5 days following vaccination. Has never had reaction like this before. Some puffiness at site.
Pt experienced a pruritic 3-4 cm circular raised area at injection site. Complained of feeling hot and sluggish, pt was afebrile. Resolved with application of Hydrocortisone cream.
Increased redness & swelling @ sites of injection, diagnosed in ER on 4/30/09 with right thigh cellulitis, treated with KEFLEX & BACTRIM
This spontaneous retrospective pregnancy report was received from a journalist and an unspecified reporter refers to unspecified number of female patients of unknown age. The patients' historical condition, current condition and concomitant medications were not reported. On unknown dates, the patients were vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (manufacturer unknown) (dose, route, frequency, expiration date and lot number were not specified) or HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (manufacturer unknown) (dose, route, frequency, expiration date and lot number were not specified) (reported as human papillomavirus vaccine). Between 2006 and 2014, 48 patients experienced ovarian damage (ovarian injury) associated with autoimmune reactions (autoimmune disorder) with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (manufacturer unknown)/ HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (manufacturer unknown). Between 2006 and May 2018, 256 patients had spontaneous abortion, 172 patients had amenorrhea and 172 patients had irregular menstruation. Unspecified number of females experienced reduction in fertility. The last menstrual period, due date and date of conception of the patients were not reported. The outcome of the events was unknown. The reporter's causality assessment between the events and the suspect therapies were not reported. Upon internal review, the events autoimmune disorder, ovarian injury and spontaneous abortion were determined to be medically significant. This is one of the several reports from the same reporter.; Sender's Comments: AU-MERCK-1406AUS003919: US-009507513-1808USA012893: US-009507513-1808USA012912:
About 1AM on the date following the SHINGRIX vaccination I started developing flu-like symptoms such as body ache, fatigue and general weakness. Also the injection site was sore.
Severe pain, swelling and rash, itching.  Rash extended from upper left deltoid to mid arm (15.5 cm) extending around to inner aspect(6cm).  Injection was given 9/7/06 and symptoms and signs still present as of this writing.  Pain and swelling is less severe today, but rash still prominent.
MODERNA COVID VACCINE #3 GIVEN 11/18/21, LOT #077C21B; pt was in Transitional Care and Rehab, when she tested positive for COVID; asymptomatic; placed in isolation room; pt also has a UTI and is taking ABX; dc'd to home on 1/31/22 where she later passed away
Presented to ED with fevers, chills, rigors, sweats, cough. Acute resp failure - secondary to COVID 19 Pneumonia - pt was started on Decadron, Oxygen and nebs. Pt was also started on IV Rocephin and Zithromax. COVID rapid test is negative and later PCR was positive. ID consult was obtained and Dr. evaluated pt. Pt was out of time limits for Remdesvir. As pt was having severe cough - Decadron was increased to 6 mg q 12 hourly. With the above - pt improved - Oxygen was weaned down to room air. Steroids were tapered down . As pt is doing better - pt is discharged home.
I got COVID on 7/13/2022, roughly 2 months after my 4th dose of the vaccine.  I had congestion, cough, headache, diarrhea and loss of smell/taste.  While I had symptoms, I took Mucinex and Tylenol to address the congestion, cough and headache.  After all of the symptoms, except for the cough had subsided, I was prescribed Promethazie-Codeine, Benzonatate and Montelukast Sodium.  I took those medications for about a week and the cough subsided.
Fever of 3 degrees, muscle aches and pains, chills, some loss of hearing, brain processing slowness, headache, loss of appetite, dizziness.rash and itchiness of arm.
Sore arm from shoulder to elbow, real bad headache,  felt light headed, upset stomach.  Events lasted for 60 hours except the sore arm, that lasted for 4 days .  Just took aspirin for all symptoms.  I always have adverse reactions to any vaccination.
Received vaccine during public innoculation on Friday 10-21-2005.  Flu-like symptoms began on Sunday, and by late Monday experienced alternate chills and fever.  Monday night great difficulty sleeping because of fever and chills.  Was able to get up and function Tuesday, but with difficulty and discomfort.  Patient has had similar reaction to public (clinic administered) flu shots in past years.
pt recv vax & allegedly became lethargic, had a sz & became apneic;EEG produced questionable findings;hosp is presumed although not documented;
After patient received vaccine, she walked to the Moderna side to wait for mother to get vaccinated. While waiting for mother, patient started to feel "dizzy."  She was assisted to chair by staff. Upon assessment, patient was warm to touch and pale color was noted to face. Patient was alert and oriented. BP 100/74, P58, SpO2 99% on room air, water given and cool compresses applied to neck. Extended monitoring in recovery area done. Patient states, "I feel much better." Patient ambulated from facility, with mother, without any difficulty. No s/sx of distress noted.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of GARDASIL (Lot number, expiry date, route and dose were not reported). The certified medical assistant reported that the vaccine was exposed to temperature of 26 F (Fahrenheit) for a total of 135 hours. No adverse effects reported. Follow-up received. Certified Medical assistant stated that other 104 children received GARDASIL. Follow up information has been received from the certified medical assistant regarding a 15 years old, male patient with no pertinent medical history reported. On 14-FEB-2013 the patient was vaccinated with a dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the right arm, dose not reported). On 16-APR-2013 the patient received another dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the left arm, dose not reported). It was reported that the patient did not seek medical attention. This is one of the several reports from the same source. Additional information is not expected.
sore throat, arthralgia & arthritis lt knee joint, erythema nodosum both legs; cough, pruritic, rash;
Bell's palsy (classic symptoms). Onset on 5/2. Seen in the ED the next day when symptoms worsened. Diagnosed with Bell's palsy (right-side of face). Weakness, asymmetry of smile, inability to completely close eyes and loss of taste on right-side of tongue.
Left arm - deltoid area with 4.0 x 3.0 cm area erythema. Induration warmth 1.0 cm area ecchymosis over injection site.
received KINRIX instead of DTAP; 3YO patient (DOB: 4/23/2018) received KINRIX instead of DTAP; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 17th December 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 17th December 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received dose of Kinrix at the age of 3 years old instead of DTAP, which led to wrong vaccine administered and inappropriate age at vaccine administration. The reporter consented to follow up.
Hives, fever, headache, sore muscles, nausea, diarrhea
That day she ran a fever, the next day she was fine, today mom noticed red in left arm, felt very hot and hard. No return p/c from mom x 3 attempted msg left at home.
Had muscles aches headache and some neck pain 15 mins after vaccination. Patient is still currently having these symptoms. Headaches and body aches have worsened.
Pt reports body itching (no rash) and swelling of (R) elbow.
Initial report received from a consumer on 03 Dec 2009: The patient, 15 month old, had mistakenly received treatment with FLUVIRIN on an unspecified date. No adverse event was reported.
later  on the day in the evening  i got my shot  my arm turn redness around the site of the injection and iched still redness and ichy the next day local reaction redness ichy
Redness, itch, rash, horizontal welts. Treatment at ER Prednisone 60mg, Famotidine 20mg, BENADRYL 50mg.
SARS CoV2 Pfizer vaccine 1 given at CVS in 4/2021. Day of vaccination, pt developed hematuria which self resolved in 2 days. Pt o/w asymptomatic.  Dose 2 of pfizer vaccine given at PCP's office. Few days after, pt developed hematuria which progressed until presentation 2 weeks post vaccination. At presentation pt was found to have hematuria, hypoalbuminemia, proteinuria, HTN, and AKI. Dx by biopsy determined IgA nephropathy.
8/24/19 SMALL RED MARK  8/26/19 BIG RED MARK ABOUT 6 INCH X 1.5INCH
pt recv vax & devel swelling on neck, arm & side of face; all the swelling was on the side of the body the inj was administered; pt recovered; No further details were provided;
This case reported by a nurse and described the occurrence of limb swelling in a 6 year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix) for prophylaxis. On 11 July 2003, the patient received Infanrix. One day post-immunization on 12-July 2003, the patient experienced limb swelling and an injection site reaction characterized by redness and warmth. The events persisted as of 16 July 2003.
Warm sensation started from the neck up approximately 30 min after vaccination.  Arm soar was began about two hours after vaccination, and was felt from the vaccination site to the wrist. This lasted throughout the night.   Later in evening stomach cramps , nausea and and migraines began.   They next day my shoulder bald and neck muscle were stiff and I was unable to move them. This lasted until day three where no symptoms were present.
a large red lesion around the injection site. With swelling,  warm to the touch. Started about an inch in diameter. After 24 hours grew to  about 3 inches in diameter.
I started to feel light headed and a bit dizzy around 8:00 PM on the day of vaccination.  The symptoms progressed to feeling week and having a chill by 10:00 PM.  I woke several time during the night feeling hot and uncomfortable.  By the time I woke up at 6:30 AM the following morning those symptoms had gone.  I had a bad headache in the morning and took acetaminophen which helped alleviate the headache.  I have felt a bit weak and tired through the day.
Covid 19  2 week history of cough, gest pain and generalized weakness pneumonia not present per CT scan, pt with some emphysema. Bradycardia with conduction system issues.  Treated with Remdesivir.
A non-serious spontaneous report of gave full dose of H1N1 LAIV in one nostril was received from a registered nurse concerning a 11-year-old female. No relevant medical history was reported for this patient. On 18-Nov-2009 the patient inadvertently received 0.2ml of H1N1, Intranasal into a single nostril. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable, and the event was considered resolved.
Fever, chills, body aches, headache, covid arm started the day after receiving the second shot. Symptoms are slowly going away 24 hours after they began. A little worse than after 1st shot.
pt recvd vax; limp, circumoral cyanosis, dec alert; no tx;
This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was unknown. It was unknown if the reporter considered the muscle pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The health care professional (HCP) was cold transferred to medical information. The HCP did not provide me with any details about the patient, the patient's experience or vaccine lot or expiration date.
dry mouth; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRY MOUTH (non-serious), outcome "unknown", described as "dry mouth".  Additional information: Reporter stated he had a friend that also had dry mouth. Reporter stated he said he also called a friend and her sister who was also an RN (Registered Nurse) and she said her friend also had dry mouth. Reporter stated that it just went away but tried to look into the website and see if that was the reported symptom and couldn't find anything, so that's why thought would call and ask.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021541863 Same reporter/ drug/ event for different patients
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; VENLAFAXINE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: Blood cholesterol: High; Blood pressure measurement: High; SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included paxlovid from 31Aug2022 to 04Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
minor soreness, red and swelling just below injection site significant lower back stiffness & dull pain - difficult to move normally  generally achy
Patient hospitalized on 9/29/21. On arrival to the ER, his sats were 70% on room air.  He was hypotensive with a blood pressure of 85/58, with a normal heart rate of 80. He was not terribly tachypneic.  He was placed on a 15 L non-rebreather mask with good results.  Chest x-ray demonstrated pulmonary edema.  COVID testing was positive.  His hemoglobin was 6.9, down from 10.1 during his recent hospitalization.  Procalcitonin was elevated, as was D-dimer.  A CTA for PE and a CT of his abdomen and pelvis was obtained.  This did not demonstrate pulmonary emboli or untoward sequelae of his recent surgery that would account for his anemia.  It did demonstrate small bilateral effusions and anasarca.  He initially had recei
Tightness in chest, throat irritation, developed productive cough. Eyes dry, itchy, eatery, feel mattery. Lower lip numb and tinglingly, feels like novacaine shot.
Fatigue , joint pain , headache, feverish , dizziness , lack of appetite and pain all over the body .No any medicine only advice to take paracetamol . Outcome is that I'm getting temporary relief back to the problem as soon as paracetamol action is over
About one month after being vaccinated he began having headaches. They increased in intensity over a period of about one year, up to the point where he had an Ischemic Stroke. He had rarely, if ever, complained about headaches prior to being vaccinated. He also began to miss time from work due to the severity of the headaches.
Organ swelling, generalized pain, extreme tiredness, dizziness, blurred vision, pain in the chest, back, legs, arms, head, gums, teeth, jaw, eyes, nose, throat, ears, neck, anxiety, panic attacks, disorder hormonal, guillan-barre symptoms, COVID symptoms, bruises, clots, cramps, spasms, shortness of breath, not being able to walk and talk well, brain fog, sluggishness, drowsiness, swollen lymph nodes throughout the body, abscesses, peripheral nerve pain, trigeminal nerves, muscle aches, joints, bones, generalized arthritis, autoimmune symptoms.
Initial misuse report received from a pharmacist on 03-October-2013. The 1-year-old patient had received a full dose of FLUZONE  0.5 ml. No adverse event was reported. List of documents held by sender: none.